A lcohol-induced liver damage is a major cause of morbidity and mortality worldwide. Ethanol-induced hepatocyte death is believed to result from a combination of oxidative stress and a cytotoxic cytokine cascade, with injury being secondary to apoptosis and necrosis. However, the mechanisms involved remain incompletely defined. 1 Transglutaminase 2 (TG2) is a member of a family of cross-linking enzymes that catalyze posttranslational modification of proteins by calcium-dependent crosslinking to form N (␥-glutamyl) lysine bonds. [2] [3] [4] In addition, it has many other functions, such as serving as a guanosine triphosphate binding protein involved in receptor signaling [2] [3] [4] and as a scaffolding protein involved in stabilizing fibronectin binding by ␤-integrins. [2] [3] [4] TG2 has been implicated in the regulation of cell growth and differentiation, and its cross-linking activity has been associated with apoptosis. [2] [3] [4] For example, accumulating evidence suggests a link between enhanced transamidating activity of TG2 and neuronal cell death, for example, enhanced expression of TG2 in patients with Alzheimer's disease and enhanced TG activity observed in patients with Huntington's disease. [2] [3] [4] We showed previously that TG2 cross-linking activity was significantly increased with carbon tetrachloride-induced liver injury in rats and in acute human liver injury. 5 However, its involvement in apoptosis remains incompletely defined and controversial. For example, enhanced expression of a short form of TG2, which is encoded by an alternatively spliced transcript, lacks guanosine triphosphatase activity, has poor cross-linking activity, and is proapoptotic, 6 although, thus far, short-form TG2 expression has only been reported in the human brain. 7, 8 We also observed previously that enhancing ␣ 1 -adrenergic receptor-coupled signaling via the G protein activity of TG2 results in decreased TG2 cross-linking and enhanced hepatocyte proliferation. Moreover, activation of TG2 cross-linking either by ethanol treatment or by Fas activation resulted in increased apoptosis and decreased hepatocyte proliferation. 9 Mice with homozygous inactivation of Tgm2, the TG2 gene (TG2 Ϫ/Ϫ mice), 10, 11 are more susceptible to toxin-induced hepatobiliary injury 12 and CCl 4 -induced liver injury. 13 Moreover, TG2 has been reported to be antiapoptotic, an effect linked both to its guanosine triphosphate binding and transamidating activity. [13] [14] [15] [16] Thus, it is still unclear if TG2 is causative for apoptosis induction or antiapoptotic, or if its apparent involvement in apoptosis is merely an epiphenomenon, and clarification of the molecular mechanism by which TG2 induces hepatic apoptosis will help answer these questions.
By using loss-and gain-of-function approaches for TG2 and Sp1 in in vitro and in vivo models, we show that TG2 plays a causative role in hepatocyte apoptosis induced by ethanol and Fas. As an underlying molecular mechanism, we show that the transcription factor Sp1 is cross-linked, oligomerized, and inactivated by nuclear TG2, resulting in reduced expression of growth factor receptors, such as c-Met, required for cell integrity. These effects define a novel proapoptotic pathway resulting in caspase-independent apoptosis accompanied by chromatin condensation, responses that can be rescued by Sp1 overexpression or by growth factor receptor activation.
Materials and Methods Materials
Recombinant human Sp1 and guinea pig TG2 were purchased from Promega (Madison, WI) and Oriental Co (Osaka, Japan), respectively. Histidine-tagged recombinant human Sp1 was made using Rapid Translation System from Roche Molecular Biochemicals (Mannheim, Germany) by coupled transcription/translation and purified using Ni-NTA agarose (Qiagen, Hilden, Germany) at 4°C. Anti-Sp1 and c-Met antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-cross-linked Sp1 (CL-Sp1) and anti-TG2 polyclonal antibody was made in rabbits and purified as detailed in Supplementary Figure  1 and text. Anti-TG2 monoclonal antibody was from Lab Vision (Fremont, CA). Cy5-/horseradish peroxidase-conjugate anti-rabbit immunoglobulin (Ig) G and tetramethylrhodamine isothiocyanate-conjugate streptavidin were from Jackson ImmunoResearch Laboratories (West Grove, PA). 5-(biotinamido) pentylamine (5-BAPA), a biotinylated primary amine substrate for TG2, was from Pierce (Rockford, IL). A broad-spectrum caspase inhibitor, zVAD-fmk, and caspase-3 specific inhibitor, zDEVD-fmk, as well as Hoechst 33258 were from Calbiochem-Novabiochem (La Jolla, CA).
The expression vector for human Sp1 (Sp1-pCIneo) was constructed as described previously. 17 A TG2 and Sp1 small interfering RNA (siRNA)-expressing lentiviral vector was constructed in the pSIH-H1 short hairpin RNA vector (SBI System Biosciences, Mountain View, CA) as detailed in Supplementary Figure 2 and text. A GC3-Luc vector, which contains 3 sequential repeats of the GC box motifs derived from the c-Met promoter and its TATA box sequence 18 upstream of the luciferase complementary DNA, was generated by inserting a synthesized oligodeoxynucleotide cassette into the pGL3 vector (Promega Corp).
Transient Transfection and Luciferase Assays
Cells were cultured as described in the Supplementary text (see Supplementary Material and Methods). Transfections using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) and luciferase assays using the Dual-Luciferase Reporter Assay System (Promega) were performed as described previously. 19 Transfection of 5 ϫ 10 5 HepG2 cells with 50 ng of Sp1-expressing vector, Sp1-pCIneo, or empty vector was performed using a microporator, MP-100, from AR Brown (Tokyo, Japan).
Preparation of Nuclear Extracts
Nuclear proteins were isolated and nuclear extracts prepared from liver tissue as previously described. 19 
Immunoprecipitation
Reaction mixtures of Sp1, TG2, and 5-BAPA, as well as nuclear extracts from TG2-transfected and 5-BAPAtreated cells, were incubated with 40 L of nonimmune rabbit IgG-conjugated agarose beads (Sigma, St Louis, MO) for 16 hours at 4°C on a rotating mixer as described previously. 17 
Western Blotting
Western blotting was performed as described previously. 19 Detailed conditions are described in the Supplementary text. (see supplemental material online at www.gastrojournal.org).
Assays of TG2 Activity
Assays of total TG2 enzymatic capacity (activity) of extracts and in situ TG2 activity were performed as described in the Supplementary text (see Supplementary Material and Methods). 5=-ATTCGATCGGGGCGGGGCGAGC-3=; or AP-1 consensus sequence, 5=-CGCTTGATGACTCAGCCGGAA-3=) and nuclear proteins (6 g) or Sp1 (25 ng), preincubated with or without TG2.
Staining of Cells and Liver Sections
Primary hepatocytes and HepG2 cells on coverslips were fixed with 10% formalin in culture medium. Cells were permeabilized and stained with various antibodies as detailed in the figure legends. Apoptotic cells of liver sections were detected using a DeadEnd Colorimetric TUNEL System (Promega). Digital images of cells and liver sections were obtained by confocal microscopy (Carl Zeiss, Inc, Oberkochen, Germany) and digital images were recorded.
Flow Cytometry and Cell Image Analysis
Ethanol-treated hepatocytes and HepG2 cells were stained with fluorescein isothiocyanate-labeled Annexin V using Annexin V-FITC Kit (Beckman Coulter, Marseille, France). They were analyzed with a fluorescence activated cell sorter (Epics Elite ESP; Beckman Coulter) or using a cell-based imaging system (Celaview RS-100; Olympus, Tokyo, Japan) after fixing and staining with both Hoechst 33258 and anti-TG2 polyclonal antibody (10 g/mL) plus Cy5-conjugate anti-rabbit IgG (1:1000).
Animals
Sprague-Dawley rats (200 -250 g) and C57BL/6 ϫ 129 SvJ mice were purchased from Japan SLC Inc (Hamamatsu, Sizuoka, Japan) or Charles River Laboratory (Wilmington, MA). TG2 Ϫ/Ϫ mice and their TG2 ϩ/ϩ littermates derived from heterozygous crosses 10 were used for the isolation of hepatocytes and in vivo liver injury experiments. All animal experiments were performed in accordance with protocols approved by the University of California Davis, University of Southern California, and RIKEN Institutional Animal Use and Care Administrative Advisory Committees. Detailed conditions for each animal experiment are described in Supplementary text.
Human Resource
Human alcohol steatohepatitis and control liver samples were obtained after informed consent and approval by the Ethics Committee for Biomedical Research, Jikei University School of Medicine (Tokyo, Japan).
Statistical Analysis
Quantitative data are shown as mean Ϯ SD or SEM. Statistical analyses were evaluated by single-factor analysis of variance test. Newman-Keuls test was used for multiple comparisons among groups. The 2-tailed Student t test was used to evaluate differences between 2 groups. P Ͻ .05 was considered statistically significant.
Results

Ethanol Increases Hepatocyte Nuclear TG2 Activity
Treatment of primary rat hepatocytes with ethanol overnight increased total TG2 enzymatic capacity (activity) both in whole cell extracts (1.5-fold, P Ͻ .01) and in nuclear fractions (2.1-fold, P Ͻ .01) ( Figure 1A) . Accumulation of TG2 to the nucleus was also observed, as evidenced by the appearance of dense clumps of fluorescent material ( Figure 1A , lower panels) and Western blot analysis (Supplementary Figure 3A) . Similar effects were observed with ethanol-treated or TG2-overexpressing human hepatocyte cell lines (Supplementary Figure  3B and C) . Ethanol-treatment dose-dependently increased the number of Annexin V-and nuclear TG2-positive cells ( Figure 1B) . Acetaldehyde, an ethanol metabolite, mimicked the effect at 1/1000 concentration (Supplementary Figure 4) . Ethanol also enhanced TG2 messenger RNA expression and the expression of importin-␣3 (Supplementary Figure 5) , which has been implicated in TG2 nuclear translocation. 20 Furthermore, whereas apoptosis was readily apparent in ethanoltreated hepatocytes from TG2 ϩ/ϩ mice (12% of cells showing fragmented nuclei), it was not observed in TG2 Ϫ/Ϫ hepatocytes ( Figure 1C ). Consistent with this morphological evidence of apoptosis, active caspase-3 levels increased in ethanol-treated TG2 ϩ/ϩ hepatocytes ( Figure 1C , lower panels).
TG2 Cross-links and Inactivates Sp1 in Cell-Free Systems
We next attempted to identify the nuclear substrate(s) that could mediate TG2-induced apoptosis. Microarray analysis of hepatocytes isolated from ethanoltreated TG2 ϩ/ϩ and TG2 Ϫ/Ϫ mice showed that ethanol increased the expression of 248 genes by Ͼ2.5-fold in a TG2-dependent manner, whereas that of 157 genes was TG2-dependently decreased (Supplementary Figure 6A) . Because the latter included genes, such as c-Met, 18 that are regulated by the transcription factor Sp1, a glutaminerich protein, we investigated if Sp1 is a target of TG2 cross-linking. Incubation of human Sp1 with guinea pig liver TG2 resulted in large CL-Sp1 complexes, as detected by Western blot analysis using a commercial anti-Sp1 antibody ( Figure 2A, lanes 2-4) . Further evidence for Sp1 being a TG2 substrate was its ability to modify Sp1 by incorporation of 5-BAPA (Figure 2A , lanes [7] [8] [9] [10] . In this study, an anti-biotin antibody recognized not only the high-molecular-weight CL-Sp1 complex identified with an anti-Sp1 antibody (lane 8) but also a 184-kilodalton band corresponding to Sp1 dimer and a fainter 92-kilodalton band corresponding to Sp1 monomer (lane 10). We attribute the greater sensitivity of the anti-biotin antibody to the incorporation of multiple 5-BAPA molecules into Sp1. Interestingly, with prolonged incubation of Sp1 with TG2, CL-Sp1 was no longer apparent with the anti-Sp1 antibody (lane 5), suggesting that heavy cross-linking masks the epitope identified by this antiserum.
Consistent with the ability of TG2 to mediate crosslinking of both the activation and DNA-binding domains of Sp1 (data not shown), after incubation with TG2, Sp1 lost both its ability to bind to its target DNA motif, the GC box ( Figure 2B , column 3), and to drive GC boxdependent transcription ( Figure 2C , lane 5).
Ethanol-Induced Hepatic Cell Apoptosis Involves Cross-linking and Inactivation of Sp1
To test if TG2-induced Sp1 cross-linking and inactivation are responsible for ethanol-induced apoptosis, we next studied the HepG2 human hepatoma cell line. Ethanol dose-dependently induced apoptosis coincident with enhanced TG2 expression and activity, accumulation of CL-Sp1, enhanced Annexin V positivity, and Sp1 transcriptional inactivation ( Figure 3A -C). Apoptosis was caspase independent as it was observed even in the presence of the caspase inhibitor z-DEVD ( Figure 3D , lane 3) and was mimicked by siRNA-mediated Sp1 knockdown ( Figure 3D, lane 7) . Moreover, whereas ethanol treatment resulted in a marked increase in Sp1 cross-linking and impaired DNA binding in hepatocytes from TG2 ϩ/ϩ mice or control HepG2 cells, these effects were minimal in cells from TG2 Ϫ/Ϫ mice or HepG2 cells overexpressing an siRNA to knockdown TG2 ( Figure 3B and C and Supplementary Figure 2A ).
TG2-Mediated Sp1 Cross-linking and Inactivation Causes Hepatic Apoptosis In Vivo
To confirm the biological relevance of these in vitro findings, we evaluated Fas-mediated hepatocellular apoptosis in vivo, because this mode of apoptosis induction contributes importantly to alcohol-induced liver damage. 21 In these studies, administration of the anti-Fas (CD95) antibody Jo2 caused liver injury in TG2 ϩ/ϩ but not in TG2 Ϫ/Ϫ mice, as evidenced by marked increases in serum alanine aminotransferase (ALT) levels from 45 U/L in untreated TG2 ϩ/ϩ animals ( Figure 4A , lane 1) to Ͼ10,000 U/L at 1 day postinjection ( Figure 4A , lane 2). Pretreatment with either putrescine or cystamine, having an inhibitory activity against TG2, attenuated this increase in serum ALT level (lanes 3 and 4, respectively). In TG2 Ϫ/Ϫ mice, Jo2 caused only a very minor increase in serum ALT level from 45 U/mL in untreated animals to 143 U/mL ( Figure 4A , lane 6). Consistent with these ALT changes, in situ terminal deoxynucleotidyl transferasemediated deoxyuridine triphosphate nick-end labeling staining of livers from Jo2-treated TG2 ϩ/ϩ mice showed abundant apoptotic cells ( Figure 4B , panel a), as well as massive cell death and extensive infiltration of inflammatory cells ( Figure 4B , panel c), which appeared to be mostly F4/80-positive mononuclear cells (Supplementary Figure 7A ). These effects were not evident in TG2 Ϫ/Ϫ mice ( Figure 4B , panels b and d) and were largely prevented by pretreatment with putrescine or cystamine (data not shown). Pretreatment with an inhibitor to the protein disulfide isomerase, bacitracin, did not affect serum ALT level (18,517 Ϯ 3371 U/L).
Next, we investigated if TG2-mediated CL-Sp1 was accompanied by hepatic apoptosis. After treatment of TG2 ϩ/ϩ animals with increasing doses of Jo2, the amount of Sp1 monomer present in liver extracts decreased (Figure 4C, lanes 1-3) , whereas Sp1 oligomers increased (Figure 4C, lanes 4 -6, 7, and 8) . In contrast, the amount of Sp1 multimers remained unchanged or decreased in the livers of Jo2-treated TG2 Ϫ/Ϫ mice ( Figure 4C, lanes 9 and  10) . Furthermore, hepatic Sp1 DNA binding activity was lost with Jo2 treatment of TG2 ϩ/ϩ but not TG2 Ϫ/Ϫ mice ( Figure 4D ). Consistent with these findings, increased hepatic nuclear TG2 and CL-Sp1 were also observed in a mouse model in which alcoholic steatohepatitis was induced by forced intragastric administration of ethanol and a high-fat diet ( Figure 4E and Supplementary Figure  7B ) and in liver specimens from patients with alcoholic steatohepatitis ( Figure 4F ). In normal mice, Sp1 knockdown induced by injection of a lentiviral vector encoding an Sp1 siRNA, but not lentivirus alone, resulted in hepatic apoptosis (Supplementary Figure 7C , arrows).
TG2-Dependent Apoptosis Accompanies Reduced Expression of Sp1 Transcriptional Targets
Finally, to obtain insights into the molecular mechanisms by which cross-linking of Sp1 results in apoptosis, we investigated if the expression of several genes whose transcription is controlled by Sp1, including Bcl-2, Bcl-xL, p21, and growth factor receptors, is altered in ethanol-treated HepG2 cells. Expression of Bcl-2 and Bcl-X L remained unchanged (data not shown), and in contrast to a previous report, 22 transactivation of a p21 responsive reporter gene did not increase with ethanol treatment (Supplementary Figure 8A) . Additionally, the nuclear localization of apoptosis-inducing factor, whose release from mitochondria was implicated in TG2-induced apoptosis, as well as induction of activating transcription factor 6, which regulates glucose-regulated protein genes encoding endoplasmic reticulum chaperones, were unchanged or minimally altered, respectively (Supplementary Figure 8B) . Of several growth factor receptors examined, steady state messenger RNA expres- 1-3) or TG2 siRNA (lanes 4 -6) were treated with 0 -200 mmol/L ethanol for 24 hours. Sp1 DNA binding activity of nuclear extracts was determined by gel shift assay using a consensus GC box as a probe. Lane 7, mixed nuclear extracts ϩ 50-fold excess of unlabeled probe (cold); lane 8, ϩ nonimmune (NI) IgG; lane 9, ϩ anti-Sp1 IgG (␣Sp1). Detailed information about the cells used is described in Supplementary Figure 2A messenger RNA expression ( Figure 5A ), and in vivo in hepatocytes prepared from Jo2-treated animals, which showed reduced expression of c-Met protein only in TG2 ϩ/ϩ cells ( Figure 5B and Supplementary Figure 8C) . Further, microarray analysis showed a 27-fold reduction in c-Met expression by ethanol treatment in TG2 ϩ/ϩ but not TG2 Ϫ/Ϫ hepatocytes, whereas TG2-dependent inhibition of tumor necrosis factor receptor and epidermal growth factor receptor expression by ethanol were only 4-and 2-fold, respectively (Supplementary Figure 6B) .
To determine if reduced expression of c-Met was due to Sp1 inactivation, we monitored transactivation of a chimeric reporter gene construct in which expression was driven by 3 tandem functional GC box motifs in the c-Met promoter. As shown in Figure 5C , ethanol-treatment dose-dependently decreased luciferase activity from this reporter gene (lanes 1-3) in HepG2 cells, this cell line being used to obviate the need to transfect primary hepatocytes, which is problematic. This reduced transactivation of the c-Met promoter was not prevented by caspase inhibition (lanes 4 -9), but was prevented by overexpression of Sp1 (lanes 10 -12) , and was mimicked by Sp1 knockdown with siRNA (lanes 13-15; see also Figure 5B , lanes 5 and 6, which confirm Sp1 siRNA-induced reduction of c-Met expression). In contrast, AP-1 luciferase activity decreased only marginally with ethanol treatment (lanes 16 -18) . Finally, we found that HGF treatment not only increased phospho-c-Met levels ( Figure 5D ) but markedly inhibited ethanol-induced death of rat hepatocytes ( Figure 5E ), indicating that reduced Sp1-mediated transcription of c-Met may at least in part directly mediate ethanol-induced apoptosis.
Discussion
Using TG2 ϩ/ϩ and TG2 Ϫ/Ϫ mice, we provide evidence that TG2 plays a primary role in hepatic injuryinduced hepatocyte apoptosis in vivo and that this effect is mediated by accumulation of TG2 in the nucleus ( Figure 6 ). This results in cross-linking and transcriptional inactivation of Sp1 and, as a consequence, impairs expression of Sp1-regulated target genes, such as the HGF receptor c-Met, which is critical for cell growth and survival ( Figure 6 ). These conclusions are supported by several lines of evidence including that (1) TG2 overexpression results in apoptosis, Sp1 cross-linking, and inactivation, effects that can be mimicked by siRNA-induced Sp1 knockdown and rescued by TG2 knockout or knockdown, or by Sp1 overexpression, (2) apoptosis induced by ethanol or Jo2 treatment is accompanied by TG2-dependent Sp1 cross-linking and inactivation, and (3) treatment with HGF markedly decreases cell death.
Sarang et al 15 reported that TG2 protects against highdose (1 g/g body wt) Jo2-induced liver injury, based on the finding that TG2 Ϫ/Ϫ mice were more sensitive to Jo2-mediated necrosis than TG2 ϩ/ϩ animals. In those studies, 15 FVB mice were used as the wild-type controls. In our hands, using wild-type littermates from heterozygous TG2 ϩ/Ϫ crosses, the high dose of Jo2 used by Sarang et al 15 caused massive hepatic necrosis, both in TG2 ϩ/ϩ and TG2 Ϫ/Ϫ mice (data not shown). Thus, the different genetic backgrounds of the TG2 ϩ/ϩ versus TG2 Ϫ/Ϫ mice used by Sarang et al 15 could have contributed to the discrepancy in our findings. However, we believe Jo2 dosage is another important factor, because we can reproduce the protective effect of TG2 silencing on hepatic injury caused by low-dose Jo2 (ie, the dose used in the present study: 0.1 g/g body wt) in the exact same TG2 Ϫ/Ϫ mice used by Sarang et al 15 ( Supplementary Figure 9) . Thus, TG2 may promote hepatic apoptosis caused by relatively low doses of Jo2, but not by higher doses. The detailed mechanisms underlying these distinct effects remain to be elucidated.
Using the same TG2 knockout mice as used by Sarang et al, 15 Nardacci et al 13 (lanes 1-8) or TG2 Ϫ/Ϫ mice (lanes 9 and 10), liver extracts were prepared and assessed by Western blotting for Sp1 monomer or CL-Sp1 using the antisera indicated. Polyvinylidene difluoride membranes from the studies in lanes 1-10 were reprobed with anti-lamin B1. (D) Twenty-four hours after administration of Jo2 to TG2 Ϫ/Ϫ (lanes 1 and 2) or TG2 ϩ/ϩ mice (lanes 3-7) , DNA binding activity of Sp1 in liver extracts was assessed by gel shift assay using a consensus GC box as the probe. Lanes 1, 3, and 5-7, controls; lanes 2 and 4, Jo2; lane 5, ϩ50-fold excess of unlabeled probe (cold); lane 6, ϩ nonimmune antibody (NI IgG); lane 7, ϩ anti-Sp1 IgG (␣Sp1). (E) Liver sections from mice with alcoholic steatohepatitis were stained with anti-CL-Sp1 (30 g/mL), anti-Sp1 (5 g/mL), or polyclonal anti-TG2 (30 g/mL) antibodies, and the signals were enhanced using an ABC kit and developed with DAB substrate. Sections were counterstained with hematoxylin. Serum ALT levels (mean Ϯ SD, n ϭ 5) were 14 Ϯ 2 U/L (controls) and 299 Ϯ 121 U/L (ethanol treated). Scale bar ϭ 50 m. (F) Human alcoholic liver and control samples were stained with anti-CL-Sp1 (30 g/mL), monoclonal anti-TG2 (30 g/mL), or H&E. Noncancerous regions of the liver from a patient with uterine cancer with hepatic metastases were used as the controls. Staining signals were enhanced using the Envisionϩ system, horseradish peroxidase, detection (Dako, Carpinteria, CA) and developed with DAB substrate. Sections were counterstained with hematoxylin. Scale bar ϭ 50 m. More than 6 mice were used for each experiment in A-E. A-F show representative findings from 3 different experiments that all gave similar results.
in CCl 4 -mediated liver injury and speculated that the observed increase in TG2 expression during the initial stages of liver fibrosis in hepatitis C virus-infected patients may protect against liver injury. However, another explanation may be that high levels of TG2 contribute to liver injury in these patients, in which case, as we have shown here in an animal model ( Figure 4A ), TG2 inhibitors may be a useful treatment for the prevention of hepatic apoptosis.
Han and Park reported that 293T cells overexpressing TG2 showed increased binding of Sp1 to its target DNA, as measured by gel electrophoretic mobility shift assay and p21 reporter construct. 22 We speculate that differences in cell types and experimental conditions, including the extent of Sp1 cross-linking, could account for these contradictory results.
Expression of a number of major apoptotic and antiapoptotic genes, such as those for caspase family mem- (lanes 1 and 2) or TG2 Ϫ/Ϫ mice (lanes 3 and 4) were treated with 0 or 100 mmol/L ethanol for 48 hours, or HepG2 cells were transfected with scrambled Sp1 siRNA oligo (control, lane 5) or Sp1 siRNA (lane 6) and incubated for 48 hours. Hepatocyte or HepG2 total cell extracts were then prepared. Lanes 7-10: Twenty-four hours after administration of either saline (-) or Jo2 (ϩ) to TG2 ϩ/ϩ (lanes 7 and 8) or TG2 Ϫ/Ϫ mice (lanes 9 and 10), animals were killed and liver extracts prepared. c-Met, glyceraldehyde-3-phosphate dehydrogenase, and Sp1 protein expression in total cell extracts or liver whole extracts was assessed by Western blotting. (C) One day after transfection of HepG2 cells with c-Met promoter GC3-Luc (lanes 1-15) or AP-1 Luc reporter (lanes 16 -18) , cells were treated with either 0 -200 mmol/L ethanol for 24 hours in the absence (lanes 1-3) or presence of 50 g/ml z-VAD (lanes 4 -6) or z-DEVD (lanes 7-9) or cotransfected with Sp1-pCIneo (lanes 10 -12) or Sp1 siRNA (lanes 13-15) vector. Results shown are means Ϯ SD (n ϭ 3). * P Ͻ .05, ** P Ͻ .01 compared with controls. (D) After treatment of HepG2 cells with 0 -100 mmol/L ethanol for 24 hours in the absence (lanes 1 and 2) or presence of 10 ng/mL HGF (lanes 3 and 4) , cell lysates were prepared and c-Met bers, Bcl proteins, apoptosis-inducing factor, and activating transcription factor 6, was unchanged or only minimally (Ͻ2-fold) altered (Supplementary Figure 8B) , indicating hepatocyte apoptosis induced by TG2-mediated CL-Sp1 is a novel cell death pathway basically independent from apoptosis-inducing factor and caspase. Ingenuity pathway analysis of genes determined by microarray analysis to be up-regulated or down-regulated in a TG2-dependent manner by Ͼ2.5-fold following ethanol treatment showed highly significant activation (P Ͻ 1 ϫ 10 Ϫ6 ) of both hepatic cell death and disease pathways, including TG2-dependent inhibition of c-Met expression. Our finding that inactivation of Sp1 by TG2-mediated cross-linking impairs transcription of Sp1-regulated target genes, such as those for growth factors that are required for normal cell functioning, is consistent with the finding that inactivation of Sp1 in neuronal cells down-regulates both dopamine and nerve growth factor receptor expression, [23] [24] [25] and that down-regulation of c-Met induces apoptosis. 26 Further, in rat hepatocytes, which are less sensitive than HepG2 cells or mouse hepatocytes to the inhibitory effects of ethanol on c-Met expression (ϳ50% reduction in c-Met), excess HGF induces significant c-Met phosphorylation of residual c-Met receptors ( Figure 5D ) and limited ethanol-induced apoptosis ( Figure 5E ). We cannot explain why Sp1 cross-linking down-regulates c-Met expression, while other Sp1-dependent genes are much less affected. We speculate that differences in Sp1 dependence may depend on the cell type and culture conditions used and that other member(s) of Sp/KLF family may compensate for the function of Sp1 in the transactivation of less affected genes. Indeed, we recently found that in TG2-and CLSp1-dependent apoptosis of acyclic retinoid-induced hepatocarcinoma, the putative target was epidermal growth factor receptor rather than c-Met (Tatsukawa et al, unpublished data, February 2008). The result of pathway analysis also suggested potential modulation of the PI3K/Akt, Tolllike receptor, and pTEN signaling pathways.
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In summary, our findings in liver cells, in in vivo models of hepatic apoptosis, and in patients with alcoholic steatohepatitis indicate that TG2 enhances apoptosis and may, indeed, underlie its initiation. The transcription factor Sp1 is cross-linked, oligomerized, and inactivated by nuclear TG2, leading to activation of a caspase-independent apoptotic process as a result of reduced expression of critical growth factor receptor genes, such as c-Met. It would also be of interest to evaluate the contribution of TG2 and Sp1 in ethanol/FasL-induced apoptosis of stellate cells in the context of liver fibrosis.
Supplementary Data
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Supplementary Materials and Methods
Microarray Analysis
After treatment of TG2 ϩ/ϩ and TG2 Ϫ/Ϫ mice with ethanol for 15 hours, total RNA was isolated from hepatocytes. Conversion to complementary RNA and biotin labeling were performed according to manufacturers' protocols. Calculation of signal intensities in each array (Affymetrix Mouse Genome 430 2.0 Array, Santa Clara, CA) and comparative analyses were performed using GeneSpring GX software (Agilent Technologies, Santa Clara, CA). After fragmentation of complementary RNA, microarray studies were performed by the RIKEN Research Resource Center.
Cell Culture
Hepatocytes, isolated from both rats and mice by 2-step collagenase digestion, were purified and cultured as described. 1 HepG2 cells were grown in RPMI 1640 medium and Dulbecco's modified Eagle medium (SigmaAldrich, Inc, St Louis, MO) supplemented with 10% fetal calf serum, respectively.
Detailed Condition of Western Blotting
Western blotting was performed as described previously 2 using anti-TG2 monoclonal (1:200 dilution), anti-TG2 polyclonal (final 2.5 g/mL), anti-Sp1 (1:200 dilution), anti-cross-linked Sp1 (final 2.5 g/mL), and anti-cleaved caspase-3 antibody (1:1000 dilution; Cell Signaling, Beverly, MA) that were probed with either horseradish peroxidase-conjugated goat anti-rabbit/ mouse IgG (1:1000 dilution; Jackson ImmunoResearch Laboratories) or horseradish peroxidase-conjugated antibiotin antibody (1:1000 dilution; Sigma). Anti-lamin B1 antibody (1:500 dilution; Santa Cruz Biotechnology) and anti-glyceraldehyde-3-phosphate dehydrogenase antibody (1:2000 dilution; Chemicon International, Temecala, CA) were used to normalize for sample loading. Reactants were detected using enhanced chemiluminescence reagents (GE Healthcare, Buckinghamshire, UK).
Detailed Conditions for Assays of TG Activity
Hepatocytes seeded on 6-well Costar plates were lysed and used to determine total TG2 enzymatic capacity (activity), with 1 U defined as the incorporation of 1 mol of [1, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]-putrescine (GE Healthcare) into 1 mg of dimethylcasein (Sigma) per minute as previously described. 3 In situ TG2 activity was detected by incorporation of 5-BAPA into the cells. Hepatocytes were incubated with 0.2 mmol/L 5-BAPA and 100 mol/L aminoguanidine for 24 hours. After washing with culture medium, cells were lysed to perform the Western blotting using anti-biotin antibodies, or cells were fixed, permeabilized, and stained with tetramethylrhodamine isothiocyanateconjugate streptavidin (1:500 dilution).
TG2 and Sp1 siRNA Stable Cell Line
A TG2 siRNA stable cell line was made by infection of lentivirus, which expresses the pSIH-H1 short hairpin RNA vector containing TG2 short hairpin RNA (SBI System Biosciences). The siRNA oligonucleotide or a lentivirusbased short hairpin RNA construct was used to silence Sp1 and TG2. The sequence of siRNA oligonucleotides is as follows: Sp1 siRNA, 5=-TGTACCAGTGGCCCTGAAT-3=; TG2 siRNA, 5=-GATGGGATCCTAGACATCT-3=. The lentivirus-based vector was prepared in 293T cells and used to infect HepG2 cells. Forty-eight to 72 hours after infection, HepG2 cells were used for several experiments.
Anti-CL-Sp1 Antibody Production
Anti-CL-Sp1 antibodies were elicited by immunization of a rabbit and the antiserum purified using protein A/agarose. The cross-linked antigen used for immunization was produced by incubating purified Sp1 with guinea pig liver TG2 and then separating the resultant highly crosslinked product from Sp1 monomer and TG2 by preparative sodium dodecyl sulfate/polyacrylamide gel electrophoresis. The bands were excised, homogenized, and mixed with MPLϩTDMϩCWS Emulsion (Ribi Adjuvant System). Immunization and bleeding were continued every week for 3 months. IgGs in the resulting immune serum that recognized un-cross-linked Sp1, as well as TG2, were removed by passing the IgG fraction through an Sp1-Sepharose column and then a TG2-Sepharose column. The concentration of IgG remaining, which specifically recognized only crosslinked Sp1, was determined using a BCA Assay Kit (Pierce, Rockford, IL).
Anti-TG2 Polyclonal Antibody
Anti-TG2 antibodies were elicited by immunization of a rabbit and the antiserum purified using protein A/agarose. TG2 from guinea pig liver used for immunization was from Oriental Co and then was separated by preparative sodium dodecyl sulfate/polyacrylamide gel electrophoresis. The bands were excised, homogenized, and mixed with MPLϩTDMϩCWS Emulsion (Ribi Adjuvant System). Immunization and bleeding were continued every week for 3 months. IgG fraction was purified by protein A/agarose (Sigma) from serum. The concentration of IgG was determined using a BCA Assay Kit (Pierce).
Jo2-Induced Acute Liver Apoptosis
Jo2, an anti-Fas antibody (0.1 g/kg in normal saline; Pharmingen Corp, San Diego, CA 4 ), was given intravenously to wild-type (C57 BL/6 ϫ 129 SvJ) or TG2 Ϫ/Ϫ mice. Some animals were treated intraperitoneally with putrescine (5 mg/kg) or cystamine (18 g/kg) 30 minutes before Jo2 injection. Animals were anesthetized 24 hours after Jo2 injection. More than 6 mice were used for each experiment, and all animals were fed a commercial diet (CE2, Clea Japan; or Purina Chow 5001, Rodent Laboratory) and water ad libitum. Blood was collected for ALT assays by a kit from Sigma Diagnostics (St Louis, MO), and liver samples were fixed for frozen sectioning in a cryostat or for preparation of paraffin-embedded sections.
Alcohol Liver Injury Model
The alcohol-induced liver injury model for the early stage of steatohepatitis was made as described previously. 5 Briefly, mice were implanted with gastrostomy catheters under general anesthesia. The animals received continuous intragastric infusion of a high-fat (35% calories as corn oil; Dyets Inc, Bethlehem, PA) diet plus ethanol for 9 weeks. More than 6 mice were used for each experiment. Intragastric ethanol feeding was performed by the Animal Core of the Southern California Research Center for ALPD and Cirrhosis at the University of Southern California. Livers were removed, fixed in 10% formalin, and embedded into paraffin. Sections were made and stained with anti-CLSp1 antibody, anti-Sp1 antibody, and anti-TG2 polyclonal antibody before hematoxylin staining. Staining signals were enhanced using an ABC kit (Vectastain; Vector Laboratories, Burlingame, CA) and developed with DAB substrate.
Reverse-Transcription Polymerase Chain Reaction
Reverse-transcription polymerase chain reaction was performed as described 6 using sets of specific primers summarized in Supplementary Table 1 .
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Supplementary Figure 6 . Microarray analyses of genes whose expression was altered in mouse hepatocytes with ethanol treatment. After hepatocytes from TG2 ϩ/ϩ or TG2 Ϫ/Ϫ mice had been treated with 0 or 100 mmol/L ethanol for 15 hours, cell lysates were prepared, RNA was extracted, and changes in whole gene expression were analyzed using the Affymetrix Mouse Genome 430 2.0 Array. (A) Numbers of genes whose expression levels were up-regulated or down-regulated by at least 2.5-fold are presented. (B) Receptor-related genes whose expression was consistently altered by at least 2.5-fold with ethanol treatment are listed. (C) Apoptosis-related genes whose expression was consistently altered by at least 2.5-fold with ethanol treatment are listed. B and C list genes whose expression was down-regulated or up-regulated in a TG2-dependent manner after 100 mmol/L ethanol treatment of hepatocytes. The result showed that c-Met expression was selectively down-regulated in TG2 ϩ/ϩ mice but not in TG2 Ϫ/Ϫ mice. 
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